Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Induction of long-term tolerance to a specific antigen using anti-CD3 lipid nanoparticles following gene therapy.

Molecular therapy. Nucleic acids·2023
Same author

The Factory of Blood Production: Hematopoietic Stem Cells.

Methods in molecular biology (Clifton, N.J.)·2022
Same author

Hematopoietic Stem Cell Mobilization: Current Collection Approaches, Stem Cell Heterogeneity, and a Proposed New Method for Stem Cell Transplant Conditioning.

Stem cell reviews and reports·2021
Same author

A Single Radioprotective Dose of Prostaglandin E<sub>2</sub> Blocks Irradiation-Induced Apoptotic Signaling and Early Cycling of Hematopoietic Stem Cells.

Stem cell reports·2020
Same author

Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation.

Nature communications·2019
Same author

Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell.

Cell·2017
Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
関連記事をすべて見る

関連する実験動画

Updated: Feb 24, 2026

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

8.1K

"バブルボーイ"病 の 遺伝子 療法

Jonathan Hoggatt1

  • 1Cancer Center and Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA 02129, USA.

Cell
|July 16, 2016
PubMed
まとめ
この要約は機械生成です。

Strimvelisという遺伝子治療は,アデノシンデアミナーゼ欠乏症による重症結合免疫不全症 (ADA- SCID) を治療します. この治療法は 骨髄のドナーがいない患者にとって 重要な選択肢です

さらに関連する動画

Production and Purification of Baculovirus for Gene Therapy Application
06:11

Production and Purification of Baculovirus for Gene Therapy Application

Published on: April 9, 2018

16.0K
Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

7.3K

関連する実験動画

Last Updated: Feb 24, 2026

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

8.1K
Production and Purification of Baculovirus for Gene Therapy Application
06:11

Production and Purification of Baculovirus for Gene Therapy Application

Published on: April 9, 2018

16.0K
Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

7.3K

科学分野:

  • 免疫学
  • 遺伝学
  • 薬理学について

背景:

  • アデノシン・デアミナーゼ (ADA) 欠乏症は,有毒な代謝物質の蓄積につながり,免疫系に深刻なダメージを与える.
  • この状態は重度の結合免疫不全 (ADA-SCID) を引き起こし,バブルボーイ病とも呼ばれます.

研究 の 目的:

  • ADA- SCIDに対するStrimvelis遺伝子療法の有効性を評価する.
  • 骨髄ドナーが不足しているADA- SCID患者の代替治療を提供するためです.

主な方法:

  • ADA欠乏症を補正するために遺伝子治療を使用します.
  • 適格なADA- SCID患者にStrimvelisを投与する

主要な成果:

  • Strimvelisは,ADA- SCIDの治療に欧州医薬品局によって承認されています.
  • 遺伝子療法は 骨髄提供者がいない患者にとって 治療の有効な経路です

結論:

  • ストリムベリスによる遺伝子治療は,ADA- SCIDの治療における重要な進歩です.
  • この治療法では,ADS-SCID患者における免疫再構成の重要な未満たされた必要性を解決します.